Inventor
Robert F. Halenbeck
Inventor
San Rafael, CA, US
Overview
Patents· 43 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides26%
A61KPreparations for medical, dental or toiletry purposes19%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests19%
C12NMicroorganisms or enzymes11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for3%
A23PShaping or working of foodstuffs, not fully covered by a single other subclass3%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
8,575,312'Compositions and methods of use for MGD-CSF in disease treatment'20138,178,109'Compositions and methods of use for MGD-CSF in disease treatment'20127,226,757'Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor'20077,186,530'Protein associated with cell stress response'20077,022,672'Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor'20066,599,706'Recombinant PR-3 and assays employing the same'20036,586,222'Recombinant PR-3 and compositions thereof'20036,323,326'Method of solubilizing, purifying, and refolding protein'20016,322,779'Recombinant human CSF-1 dimer and compositions thereof'20016,319,896'Method of solubilizing, purifying, and refolding protein'20016,204,020'DNA encoding N.gradient.2 CSF-1 (short form) and carboxy truncated fragment thereof'20016,156,300'Point mutants of N.gradient.2 CSF-1 and carboxy truncated fragments thereof'20006,146,851'DNA encoding NV2 (long form) and carboxy truncated fragments thereof'20006,117,422'N.gradient.2-CSF-1(long form) and carboxy truncated fragments thereof'20006,103,224'N.gradient.2 CSF-1 (short form) and carboxy truncated fragments thereof'20006,069,127'Secreted mac-2-binding glycoprotein'20006,025,146'Identification of M-CSF agonists and antagonists'20005,998,378'Compositions for the inhibition of TNF hormone formation and uses thereof'19995,965,382'Nucleic acid encoding secreted Mac-2 binding glycoprotein'19995,866,114'Crystallization of M-CSF.alpha.'19995,861,150'Recombinant human CSF-1 dimer and compositions thereof'19995,843,693'Assay method for screening for inhibitors of proTNF conversion'19985,830,684'Native type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancer'19985,736,340'Secreted Mac-2-binding glycoprotein'19985,681,719'DNA encoding N- and C- terminally truncated colony stimulating factor-1 variants'19975,672,343'N- 3 deletion mutants of the long form of CSF-1'19975,651,963'Heterodimers forms of CSF-1 and pharmaceutical compositions thereof'19975,643,563'N-.gradient.3 deletion mutants of the short form of CSF-1'19975,644,035'Method for purifying secreted Mac-2-binding glycoprotein'19975,573,930'DNA encoding various forms of colony stimulating factor-1'1996RE035171'Compositions for detecting ras gene proteins and cancer therapeutics'19965,491,065'Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF'19965,234,839'Compositions for detecting ras gene proteins and cancer therapeutics'19935,206,344'Interleukin-2 muteins and polymer conjugation thereof'19935,116,943'Oxidation-resistant muteins of Il-2 and other protein'19925,104,975'Compositions for detecting ras gene proteins and cancer therapeutics'19924,931,543'Process for recovering microbially produced interleukin-2'19904,929,700'Production of purified, biologically active, bacterially produced recombinant human CSF-1'19904,752,585'Oxidation-resistant muteins'19884,572,798'Method for promoting disulfide bond formation in recombinant proteins'19864,569,910'Methods and reagents for pyranosone production'19864,569,913'P. obtusus pyranose-2-oxidase preparation'19864,568,645'Fungal pyranose-2-oxidase preparations'1986Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1986–1992Patents assigned to CETUS CORP (9)· patent assignee history
1986–2007Based in San Rafael, CA, US· patent location history
1993–1996Patents assigned to CETUS ONCOLOGY CORP (5)· patent assignee history
1997–2007Patents assigned to CHIRON CORP (25)· patent assignee history
2007Based in San Bernardino, CA, US· patent location history
2012–2013Patents assigned to BEHRENS DIRK (2)· patent assignee history
2012–2013Patents assigned to BOSCH ELIZABETH (2)· patent assignee history
2012–2013Based in San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHIRON CORP | 25 | 1997–2007 |
| CETUS CORP | 9 | 1986–1992 |
| CETUS ONCOLOGY CORP | 5 | 1993–1996 |
| BEHRENS DIRK | 2 | 2012–2013 |
| BOSCH ELIZABETH | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Rafael, California, US | 40 | 1986–2007 |
| San Francisco, California, US | 2 | 2012–2013 |
| San Bernardino, California, US | 1 | 2007 |